Skip to main content

David Rodriguez Luna

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

David Rodriguez Luna

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

Projects

Influencia de factores clínicos, marcadores de neuroimagen y parámetros de laboratorio en el control de la presión arterial tras una hemorragia intracerebral aguda

IP: David Rodriguez Luna
Collaborators: Noelia Rodríguez Villatoro, Manuel Requena Ruiz, Olalla Pancorbo Rosal
Funding agency: Instituto de Salud Carlos III
Funding: 40000
Reference: PI23/01061
Duration: 01/01/2024 - 31/12/2026

HARMONICS. Harmonization and Implementation of High Value Stroke Care

IP: Carlos Molina Cateriano
Collaborators: Maria Baladas Orti, Ester Sanchez Gavilan, Cristina Guirao Martinez, Estefania Montiel, Marina Jimenez Iglesias, Lidia Garcia Guillamón, Federica Rizzo, Marta Aurora Rubiera Del Fueyo, David Rodriguez Luna, Manuel Requena Ruiz, Marta Olive Gadea, Alvaro Garcia Tornel Garcia Camba, Marc Rodrigo Gisbert
Funding agency: EUROPEAN COMMISSION
Funding: 468090
Reference: HARMONICS_EIT-HEALTH-BP2022
Duration: 01/01/2022 - 31/12/2024

TRUSTroke: TRUSTWORTHY PREDICTION OF STROKE OUTCOME ON A FEDERATED LEARNING INFRASTRUCTURE

IP: Carlos Molina Cateriano
Collaborators: Estela Sanjuan Menendez, Laura Rivera Sanchez, Federica Rizzo, Marta Aurora Rubiera Del Fueyo, David Rodriguez Luna
Funding agency: EUROPEAN COMMISSION
Funding: 760000
Reference: TRUSTROKE_HE-HLTH-STAYHLTH2022
Duration: 01/05/2023 - 30/04/2027

Monitorización hemodinámica de la hemorragia intracerebral

IP: David Rodriguez Luna
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 60000
Reference: INT21/00015
Duration: 01/01/2022 - 31/12/2023

Related news

UMBRELLA, a consortium of over 20 public and private partners, kicks off this week with the aim of revolutionising the entire stroke care pathway in Europe by adopting a holistic approach that covers stroke diagnosis, prevention and care.

The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.

Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.

Related professionals

Santos Ortega, Alba

Santos Ortega, Alba

Predoctoral researcher
Cardiovascular Diseases
Read more
Xavier Cañas Perea

Xavier Cañas Perea

Director/a d'Àrea
Clinical Research Development Directorate
Read more
Ruiz Esteve, Fernando

Ruiz Esteve, Fernando

Research technician
Neurovascular Diseases
Read more
Marcos Prieto, Susana

Marcos Prieto, Susana

Research technician
Molecular Medical Imaging
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.